SOLUFOS
Therapeutic area
Antibiotics
Manufacturer
TOLL MANUFACTURING SERVICES, S.L., Spain (Packing: EDEFARM, S.L., Spain)
Visa Number
VN-22523-20
Issuing date
26/06/2020
Applicant company
Orioled Hub SIA
Active ingredient
Fosfomycin calcium
Content
500mg
Indication
Solufos is indicated for the treatment of the following severe infections:
Deep skin infections, cystitis, otitis media, sinusitis, stye, dacryocystitis, infectious enteritis.
Dosage
Adults: 2 - 3 g fosfomycin 3 or 4 times daily.
Children: 40 - 120 mg fosfomycin/kg 3 or 4 times daily.
Dosage can be adjusted according to age and clinical condition.
Shelf life
48
Dosage Form
Hard capsule
Package
Box of 1 bottle of 24 capsules
Contact